Disease details

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05740722 (ClinicalTrials.gov)	March 1, 2023	30/1/2023	Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis	Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis: A Randomised Controlled Trial: The NORSEMAN Study	Multiple Sclerosis;Progressive Multiple Sclerosis	Dietary Supplement: Nicotinamid riboside;Dietary Supplement: Placebo	Haukeland University Hospital	NULL	Not yet recruiting	18 Years	65 Years	All	300	Phase 2	Norway
2	NCT05046535 (ClinicalTrials.gov)	September 1, 2021	5/9/2021	The Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple Sclerosis	The Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple Sclerosis	Multiple Sclerosis	Behavioral: Sleep quality and physical activity;Genetic: Nicotine dependence;Diagnostic Test: Nicotine and cotinine serum levels;Behavioral: Smoking	University of Jordan	NULL	Recruiting	18 Years	N/A	All	80		Jordan